Patient comprehension of preemptive pharmacogenomic results
As preemptive PGx testing is considered for implementation in primary care settings, care must be taken to support patients with preexisting prescriptions to ensure adequate understanding of the immediate relevancy and actionability of PGx results in their healthcare.
Authors
- Suzette J. Bielinski (ORCID: https://orcid.org/0000-0002-2905-5430)
- Richard R. Sharp (ORCID: https://orcid.org/0000-0001-5441-2084)
- Joel E. Pacyna (ORCID: https://orcid.org/0000-0002-3103-7805)
- Janet E. Olson
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1080/14622416.2025.2565994
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00